Literature DB >> 2112955

Mechanism of cholera toxin activation by a guanine nucleotide-dependent 19 kDa protein.

M Noda1, S C Tsai, R Adamik, J Moss, M Vaughan.   

Abstract

Cholera toxin causes the devastating diarrheal syndrome characteristic of cholera by catalyzing the ADP-ribosylation of Gs alpha, a GTP-binding regulatory protein, resulting in activation of adenylyl cyclase. ADP-ribosylation of Gs alpha is enhanced by 19 kDa guanine nucleotide-binding proteins known as ADP-ribosylation factors or ARFs. We investigated the effects of agents known to alter toxin-catalyzed activation of adenylyl cyclase on the stimulation of toxin- and toxin subunit-catalyzed ADP-ribosylation of Gs alpha and other substrates by an ADP-ribosylation factor purified from a soluble fraction of bovine brain (sARF II). In the presence of GTP, sARF II enhanced activity of both the toxin catalytic unit and a reduced and alkylated fragment ('A1'), as a result of an increase in substrate affinity with no significant effects on Vmax. Activation of toxin was independent of Gs alpha and was stimulated 4-fold by sodium dodecyl sulfate, but abolished by Triton X-100. sARF II therefore serves as a direct allosteric activator of the A1 protein and may thus amplify the pathological effects of cholera toxin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2112955     DOI: 10.1016/0304-4165(90)90076-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

1.  Biochemical relationships between the 53-kilodalton (Exo53) and 49-kilodalton (ExoS) forms of exoenzyme S of Pseudomonas aeruginosa.

Authors:  S Liu; T L Yahr; D W Frank; J T Barbieri
Journal:  J Bacteriol       Date:  1997-03       Impact factor: 3.490

2.  Identification of motifs in cholera toxin A1 polypeptide that are required for its interaction with human ADP-ribosylation factor 6 in a bacterial two-hybrid system.

Authors:  M G Jobling; R K Holmes
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

3.  Functional domains of Pseudomonas aeruginosa exoenzyme S.

Authors:  D A Knight; V Finck-Barbançon; S M Kulich; J T Barbieri
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

Review 4.  The family of bacterial ADP-ribosylating exotoxins.

Authors:  K M Krueger; J T Barbieri
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

5.  ADP-ribosylation factors: a family of approximately 20-kDa guanine nucleotide-binding proteins that activate cholera toxin.

Authors:  C F Welsh; J Moss; M Vaughan
Journal:  Mol Cell Biochem       Date:  1994-09       Impact factor: 3.396

Review 6.  Activation of toxin ADP-ribosyltransferases by eukaryotic ADP-ribosylation factors.

Authors:  J Moss; M Vaughan
Journal:  Mol Cell Biochem       Date:  1999-03       Impact factor: 3.396

7.  Identification in traditional herbal medications and confirmation by synthesis of factors that inhibit cholera toxin-induced fluid accumulation.

Authors:  Hiroshi Oi; Daisuke Matsuura; Masami Miyake; Masamiti Ueno; Izumi Takai; Takeshi Yamamoto; Masayoshi Kubo; Joel Moss; Masatoshi Noda
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

8.  Isolation of an amino-terminal deleted recombinant ADP-ribosylation factor 1 in an activated nucleotide-free state.

Authors:  J X Hong; X Zhang; J Moss; M Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

Review 9.  Regulating the large Sec7 ARF guanine nucleotide exchange factors: the when, where and how of activation.

Authors:  John Wright; Richard A Kahn; Elizabeth Sztul
Journal:  Cell Mol Life Sci       Date:  2014-04-13       Impact factor: 9.261

10.  Activation of Escherichia coli heat-labile enterotoxins by native and recombinant adenosine diphosphate-ribosylation factors, 20-kD guanine nucleotide-binding proteins.

Authors:  C M Lee; P P Chang; S C Tsai; R Adamik; S R Price; B C Kunz; J Moss; E M Twiddy; R K Holmes
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.